Clinical commentary on 'Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis', by Foley et al

Abstract

This clinical commentary discusses the occurrence of drug-induced aseptic meningitis in patients undergoing natalizumab treatment and other immunotherapies.

Keywords: Natalizumab; adverse drug reaction; disease-modifying therapies; drug-induced aseptic meningitis.